Christine Lang is an entrepreneur in biotechnology and a consultant on bioeconomy. She has been Co-Chair of the German Bioeconomy Council and she is initiator of the Global Bioeconomy Summit series. She is Associate Professor for Microbiology and Molecular Genetics at the Technical University Berlin and vice president of the German Association of General and Applied Microbiology (VAAM). In 2001, Lang founded Organobalance GmbH, which became part of Novozymes S.A. in 2016 and was CEO till 2018. Christine Lang is also co-founder and CSO of BELANO medical AG that focuses on the development of microbiotic products for human health.
Publications and activities
B. El-Chichakli, J. von Braun, C. Lang, D. Barben, J. Phelps (2016) Policy: Five cornerstones of a global bioeconomy. Nature 535: 221-223